#BEGIN_DRUGCARD DB03357

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
90-64-2

# ChEBI_ID:
32800

# Chemical_Formula:
C8H8O3

# Chemical_IUPAC_Name:
(2S)-2-hydroxy-2-phenylacetic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
0.62

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
1.81E+005 mg/L (at 25 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
(S)-Mandelic Acid

# HET_ID:
SMN

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C8H8O3/c9-7(8(10)11)6-4-2-1-3-5-6/h1-5,7,9H,(H,10,11)/t7-/m0/s1

# InChI_Key:
InChIKey=IWYDHOAUDWTVEP-ZETCQYMHSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C01984

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3357

# Mechanism_Of_Action:
Not Available

# Melting_Point:
119 °C

# Molecular_Weight_Avg:
152.1473

# Molecular_Weight_Mono:
152.047344122

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1MDL

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.66

# Predicted_LogS:
-0.96

# Predicted_Water_Solubility:
1.68e+01 g/l

# Primary_Accession_No:
DB03357

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
439616

# PubChem_Substance_ID:
46507928

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02923

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O[C@H](C(O)=O)C1=CC=CC=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:10 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
3.41 (at 25 °C)

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M19043

# Drug_Target_1_GenBank_ID_Protein:
151352

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
mdlA

# Drug_Target_1_Gene_Sequence:
>1080 bp
ATGAGTGAAGTACTGATTACCGGCCTGAGGACGCGGGCCGTCAATGTCCCATTGGCCTAC
CCCGTTCACACCGCTGTTGGAACTGTTGGCACAGCGCCTCTTGTTCTGATCGACCTGGCC
ACCAGTGCCGGCGTGGTAGGCCATTCCTACCTGTTCGCATACACCCCCGTTGCGTTGAAG
TCGCTGAAGCAGCTCCTGGACGACATGGCAGCCATGATCGTCAACGAACCATTGGCACCG
GTTAGCTTGGAAGCCATGCTCGCAAAACGCTTCTGCCTGGCAGGTTATACGGGATTGATC
CGAATGGCCGCTGCTGGCATCGATATGGCAGCTTGGGATGCGCTGGGCAAGGTTCACGAA
ACGCCACTAGTAAAACTCCTCGGCGCGAACGCTCGACCAGTTCAGGCTTATGACAGCCAC
AGCTTGGATGGAGTCAAACTCGCGACTGAGCGCGCTGTGACCGCAGCAGAACTCGGATTC
CGGGCGGTTAAGACCAAGATCGGCTATCCGGCATTGGATCAAGATCTGGCAGTCGTGCGC
AGCATACGCCAAGCAGTAGGTGACGACTTCGGCATCATGGTCGACTACAACCAGAGTTTG
GATGTACCAGCCGCAATCAAACGCAGCCAGGCGCTGCAGCAAGAGGGCGTCACCTGGATT
GAAGAGCCGACGCTTCAACACGATTACGAAGGCCATCAGCGCATTCAAAGCAAGCTCAAT
GTGCCCGTCCAGATGGGTGAGAACTGGCTCGGCCCTGAGGAGATGTTCAAAGCATTGAGC
ATCGGTGCATGCCGGTTGGCTATGCCAGATGCAATGAAGATCGGTGGCGTGACGGGCTGG
ATCCGAGCCAGTGCACTCGCACAACAATTCGGTATTCCAATGTCCAGCCACCTGTTCCAA
GAAATCAGCGCTCACCTGCTAGCCGCCACCCCAACTGCGCATTGGCTGGAGCGTTTGGAT
CTCGCCGGCAGCGTCATCGAGCCTACTCTTACATTTGAGGGCGGAAATGCTGTGATTCCG
GATCTCCCTGGCGTTGGGATCATCTGGCGCGAGAAAGAAATCGGGAAATATCTGGTGTAA

# Drug_Target_1_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_1_General_References:
1892834	Neidhart DJ, Howell PL, Petsko GA, Powers VM, Li RS, Kenyon GL, Gerlt JA: Mechanism of the reaction catalyzed by mandelate racemase. 2. Crystal structure of mandelate racemase at 2.5-A resolution: identification of the active site and possible catalytic residues. Biochemistry. 1991 Sep 24;30(38):9264-73.
1909893	Landro JA, Kallarakal AT, Ransom SC, Gerlt JA, Kozarich JW, Neidhart DJ, Kenyon GL: Mechanism of the reaction catalyzed by mandelate racemase. 3. Asymmetry in reactions catalyzed by the H297N mutant. Biochemistry. 1991 Sep 24;30(38):9274-81.
2215699	Neidhart DJ, Kenyon GL, Gerlt JA, Petsko GA: Mandelate racemase and muconate lactonizing enzyme are mechanistically distinct and structurally homologous. Nature. 1990 Oct 18;347(6294):692-4.
2271624	Tsou AY, Ransom SC, Gerlt JA, Buechter DD, Babbitt PC, Kenyon GL: Mandelate pathway of Pseudomonas putida: sequence relationships involving mandelate racemase, (S)-mandelate dehydrogenase, and benzoylformate decarboxylase and expression of benzoylformate decarboxylase in Escherichia coli. Biochemistry. 1990 Oct 23;29(42):9856-62.
2831968	Ransom SC, Gerlt JA, Powers VM, Kenyon GL: Cloning, DNA sequence analysis, and expression in Escherichia coli of the gene for mandelate racemase from Pseudomonas putida. Biochemistry. 1988 Jan 26;27(2):540-5.
7893689	Mitra B, Kallarakal AT, Kozarich JW, Gerlt JA, Clifton JG, Petsko GA, Kenyon GL: Mechanism of the reaction catalyzed by mandelate racemase: importance of electrophilic catalysis by glutamic acid 317. Biochemistry. 1995 Mar 7;34(9):2777-87.
7893690	Kallarakal AT, Mitra B, Kozarich JW, Gerlt JA, Clifton JG, Petsko GA, Kenyon GL: Mechanism of the reaction catalyzed by mandelate racemase: structure and mechanistic properties of the K166R mutant. Biochemistry. 1995 Mar 7;34(9):2788-97.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2726

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
38565

# Drug_Target_1_Name:
Mandelate racemase

# Drug_Target_1_Number_of_Residues:
359

# Drug_Target_1_PDB_ID:
1MDR

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01188	MR_MLE
PF02746	MR_MLE_N

# Drug_Target_1_Protein_Sequence:
>Mandelate racemase
MSEVLITGLRTRAVNVPLAYPVHTAVGTVGTAPLVLIDLATSAGVVGHSYLFAYTPVALK
SLKQLLDDMAAMIVNEPLAPVSLEAMLAKRFCLAGYTGLIRMAAAGIDMAAWDALGKVHE
TPLVKLLGANARPVQAYDSHSLDGVKLATERAVTAAELGFRAVKTKIGYPALDQDLAVVR
SIRQAVGDDFGIMVDYNQSLDVPAAIKRSQALQQEGVTWIEEPTLQHDYEGHQRIQSKLN
VPVQMGENWLGPEEMFKALSIGACRLAMPDAMKIGGVTGWIRASALAQQFGIPMSSHLFQ
EISAHLLAATPTAHWLERLDLAGSVIEPTLTFEGGNAVIPDLPGVGIIWREKEIGKYLV

# Drug_Target_1_Reaction:
(S)-mandelate = (R)-mandelate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
(S)-mandelate = (R)-mandelate

# Drug_Target_1_SwissProt_ID:
P11444

# Drug_Target_1_SwissProt_Name:
MANR_PSEPU

# Drug_Target_1_Synonyms:
EC 5.1.2.2
MR

# Drug_Target_1_Theoretical_pI:
6.04

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03357
